Mandate

vinge advises on sale of Grolls

May 06, 2016

The purchaser is Swedol, a leading supplier of tools, personal protection equipment and accessories for professional users in Sweden and Norway. The transaction is subject to the approval of the Swedish Competition Authority.

Vinge’s team consisted of partners Jonas Johansson and Johan Winnerblad together with, among others, associates Gustav Tengblad, Andrea Ahlgren, Helena Håkansson and Eleonor Kjellén as well as project assistants Josefin Backlund, Christoffer Widström and Anna Hellohf.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026